Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nalbuphine vs Midazolam with Bupivacaine for C-Section Analgesia
NCT03918187Phase 1Completed
- Sponsor
- Zagazig University
- Start
- Apr 2019
- Primary completion
- Aug 2019
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of nalbuphine and midazolam in postoperative pain (3 arms), sponsored by Zagazig University. Primary endpoints: Effective analgesic time, Total postoperative analgesic dose at 24 hours and 2 more. Started Apr 2019; status: completed.
02
Drugs
nalbuphinemidazolam
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT03918187.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03918187.